Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Allergy and Immunology
/ Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Complimentary
Categories:
Activity Type
,
Allergy and Immunology
,
ANCC
,
CME
,
Credit Type
,
Family Medicine
,
Internal Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Physician
,
Physician Assistant
,
Profession
,
Pulmonology
Related products
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Read more
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
Scroll To Top